Navigation Links
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Date:12/11/2008

CARY, N.C., Dec. 11 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, today provided an update on the status of its integration activities following the closing of the business combination of Critical Therapeutics, Inc. and Cornerstone BioPharma Holdings, Inc. on October 31, 2008, and the renaming of the combined company as Cornerstone Therapeutics Inc. (the Company).

Following the October 31, 2008 closing, the Company has been taking action to effectively and efficiently combine the operations of the two companies. In completing the integration, the Company has achieved a number of key milestones:

  • The Company has discontinued all former Critical Therapeutics research projects and completed a review of those research projects to identify promising technologies suitable for outlicensing to third parties. As a result of this review, the Company has initiated a process to seek potential licensees for certain technologies, including the alpha 7 mediated anti-inflammatory pathway program.
  • The Company completed a restructuring of former Critical Therapeutics officers and employees that resulted in Scott Townsend, General Counsel and Executive Vice President of Legal Affairs, and 12 former Critical Therapeutics sales representatives remaining with Cornerstone.
  • The former Critical Therapeutics facility in Lexington, MA has been vacated and the sublease terminated.

Aggregate revenues from the Company's products have continued to be strong in the fourth quarter. The Company anticipates 2008 net revenues to be in excess of $64 million, which will include revenues attributable to ZYFL
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-A...eloper and provider of vaccines, announced today t...establish Sinovac (Dalian) Vaccine,Technology Co.,...lop, produce,and commercialize human-use vaccines....nce in developing and commercializing world-class ...
(Date:11/24/2009)... Ambassador to also Visit De...24, 2009 -- , , ,Who: David Appia, French Ambassad...CEO of the Invest in France Agency, , , , ,What: ...o discuss recent pro-business initiatives adopted ... and academic landscape for innovation and develop...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCa...will be presenting at the NASDAQ OMX conference on...:45 AM US/CST. Interested parties may listen via l... http://inve s tor.sig m a a ldrich.com/ ...is file. ,, About Sigma-Aldrich: Sigma-Al...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-As...e Food & Drug Administration (SFDA) has approv...for its oral insulin project,(Nodlin), an innovati...,approval allows Biolaxy to initiate its first pha...rder characteristic of high blood glucose and poor...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... , Ambion has developed a complete line...croRNAs (miRNAs). Recently, we introduced the mir...ng of the mir Vana miRNA Labeling Kit , an... tools for interrogating , miRNA function a...recursor , Molecules, Anti-miR miRNA Inhibi...
... Remove >90% of mammalian RNA from , ... Simple procedure takes less than 2 hou...cies , Seamless integration with ...rification Kit , Enables micro...erial RNA isolated from host cells , ...
..., Sonal Patel, and David Quilter , ... , Efficient and cost-effe... aRNA in a high throughput format , ... Rapid, reliable, and consisten...science researchers need an , efficient and...
Other Biology Technology:Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 2Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 3Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 4Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 5Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 6Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 7Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 8Bacterial RNA Isolation From Infected Eukaryotic Hosts 2Bacterial RNA Isolation From Infected Eukaryotic Hosts 3Bacterial RNA Isolation From Infected Eukaryotic Hosts 4Bacterial RNA Isolation From Infected Eukaryotic Hosts 5Bacterial RNA Isolation From Infected Eukaryotic Hosts 6Automated RNA Amplification for Arrays 2Automated RNA Amplification for Arrays 3Automated RNA Amplification for Arrays 4Automated RNA Amplification for Arrays 5
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...omic-level action of a remarkable class of ring-sh...ers with the Lawrence Berkeley National Laboratory...rystallography beamline at the Advanced Light Sour...in gene expression and replication, and are vital ...s infectious agents, such as the human papillomavi...
(Date:11/24/2009)...constitutes fish food is a matter of debate. A hig...h get almost 50 percent of their carbon from trees...n the terrestrial and aquatic ecosystems. , But ...ws this is not likely to be true. Algae provide a ...according to research published this week in the ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 1Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 2Next generation microcapsules deliver chemicals on demand 10562 1UD start up company prepares to commercialize novel detector for medical military applications 10557 1UD start up company prepares to commercialize novel detector for medical military applications 10557 2UD start up company prepares to commercialize novel detector for medical military applications 10557 3UD start up company prepares to commercialize novel detector for medical military applications 10557 4
...lobe, hundreds of millions of acres of once-produc... a new report from researchers at Stanford Univers...his land was used to grow crops for conversion int...thout worsening the world food shortage or contrib...production for contributing to recent global food ...
...DC Engineered nanoscale materials (ENMs), which c...its for use in food packaging, raise new safety ev...ccording to a report released today by the Project...y Manufacturers Association (GMA). , The food-pa... share an interest in ensuring that any possible s...
...daylong event to help forge an agenda for maintain...tecting scientists from political meddling and cor...e NASA Goddard Institute for Space Studies, will s...ight Sides of Global Warming." Dr. Hansen is consi...nge and the need to take immediate action to curb ...
Other Biology News:Stanford study: Bioenergy potential of reviving abandoned agricultural land 2Stanford study: Bioenergy potential of reviving abandoned agricultural land 3Stanford study: Bioenergy potential of reviving abandoned agricultural land 4Use of nanomaterials in food packaging poses regulatory challenges 2NASA scientist James Hansen to speak at July 11 conference on 'Rejuvenating Public Sector Science' 2
...on's most advanced personal gradient option PCR ma...rd software and a large graphical display for easy...acy and simplicity in thermal cycling, the Px2 inc...lt up on years of PCR experience. The combination ...
Extensor Control & Template from ABgene
Normal Guinea Pig Serum from IDS Ltd
Lambda Control Kit from ABgene
Biology Products: